Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS One ; 8(2): e55798, 2013.
Article in English | MEDLINE | ID: mdl-23405216

ABSTRACT

We compared exemplar strains from two hypervirulent clonal complexes, strain NMB-CDC from ST-8/11 cc and strain MC58 from ST-32/269 cc, in host cell attachment and invasion. Strain NMB-CDC attached to and invaded host cells at a significantly greater frequency than strain MC58. Type IV pili retained the primary role for initial attachment to host cells for both isolates regardless of pilin class and glycosylation pattern. In strain MC58, the serogroup B capsule was the major inhibitory determinant affecting both bacterial attachment to and invasion of host cells. Removal of terminal sialylation of lipooligosaccharide (LOS) in the presence of capsule did not influence rates of attachment or invasion for strain MC58. However, removal of either serogroup B capsule or LOS sialylation in strain NMB-CDC increased bacterial attachment to host cells to the same extent. Although the level of inhibition of attachment by capsule was different between these strains, the regulation of the capsule synthesis locus by the two-component response regulator MisR, and the level of surface capsule determined by flow cytometry were not significantly different. However, the diplococci of strain NMB-CDC were shown to have a 1.89-fold greater surface area than strain MC58 by flow cytometry. It was proposed that the increase in surface area without changing the amount of anchored glycolipid capsule in the outer membrane would result in a sparser capsule and increase surface hydrophobicity. Strain NMB-CDC was shown to be more hydrophobic than strain MC58 using hydrophobicity interaction chromatography and microbial adhesion-to-solvents assays. In conclusion, improved levels of adherence of strain NMB-CDC to cell lines was associated with increased bacterial cell surface and surface hydrophobicity. This study shows that there is diversity in bacterial cell surface area and surface hydrophobicity within N. meningitidis which influence steps in meningococcal pathogenesis.


Subject(s)
Bacterial Adhesion/physiology , Bronchi/metabolism , Cell Size , Lipopolysaccharides/metabolism , Meningococcal Infections/microbiology , Neisseria meningitidis/metabolism , Neisseria meningitidis/pathogenicity , Pharyngeal Neoplasms/microbiology , Blotting, Western , Cells, Cultured , Electrophoretic Mobility Shift Assay , Fimbriae, Bacterial/metabolism , Flow Cytometry , Glycosylation , Humans , Hydrophobic and Hydrophilic Interactions , Meningococcal Infections/metabolism , Meningococcal Infections/pathology , N-Acetylneuraminic Acid/metabolism , Pharyngeal Neoplasms/metabolism , Pharyngeal Neoplasms/pathology , Phenotype , RNA, Messenger/genetics , Real-Time Polymerase Chain Reaction , Reverse Transcriptase Polymerase Chain Reaction
2.
Infect Immun ; 75(12): 5788-97, 2007 Dec.
Article in English | MEDLINE | ID: mdl-17908814

ABSTRACT

Chemokines play an important role in inflammation and infection due to their ability to recruit cells of innate and adaptive immunity. Here we examined mouse macrophage chemokine responses during intracellular infections with high- and low-virulence Toxoplasma gondii strains. The high-virulence type I strain RH induced a large panel of CC-type chemokines, whereas responses elicited by strains PTG (type II) and M7741 (type III) were much weaker. Strikingly, the T. gondii-induced chemokine response occurred independently of signaling through the Toll-like receptor adaptor MyD88. Instead, production of chemokines during infection was heavily dependent upon phosphoinositide-3-kinase signaling pathways. Because infection with type I strains such as RH results in an uncontrolled proinflammatory cytokine response, we hypothesize that this virulence phenotype is a consequence of early strong induction of chemokines by type I, but not type II or III, Toxoplasma strains.


Subject(s)
Chemokines, CC/biosynthesis , Macrophages/immunology , Myeloid Differentiation Factor 88/metabolism , Phosphatidylinositol 3-Kinases/metabolism , Toxoplasma/immunology , Toxoplasmosis/immunology , Animals , Chemokine CCL17/immunology , Chemokines, CC/genetics , Chemokines, CC/immunology , Female , Gene Expression Profiling , Macrophages/enzymology , Mice , Mice, Inbred C57BL , Myeloid Differentiation Factor 88/immunology , Phosphatidylinositol 3-Kinases/genetics , Phosphatidylinositol 3-Kinases/immunology , Signal Transduction , Toxoplasma/metabolism , Toxoplasma/pathogenicity , Toxoplasmosis/enzymology , Toxoplasmosis/microbiology , Virulence
3.
Protein Expr Purif ; 51(2): 170-8, 2007 Feb.
Article in English | MEDLINE | ID: mdl-16950635

ABSTRACT

Pertussis toxoid, diphtheria toxoid, and tetanus toxoid are key components of diphtheria-tetanus-acellular pertussis vaccines. The efficacy of the vaccines is well documented, however, the vaccines are expensive partly because the antigens are derived from three different bacteria. In this study, a fusion protein (PDT) composed of the immunoprotective S1 fragment of pertussis toxin, the full-length non-toxic diphtheria toxin, and fragment C of tetanus toxin was constructed via genetic means. The correct fusion was verified by restriction endonuclease analysis and Western immunoblotting. Escherichia coli carrying the recombinant plasmid (pCoPDT) produced a 161kDa protein that was recognized by antibodies specific to the three toxins. The expression of the PDT protein was inducible by isopropyl-beta-d-thio-galactoside but the total amount of protein produced was relatively low. Attempts to improve the protein yield by expression in an E. coli strain (Rosetta-gami 2) that could alleviate rare-codon usage bias and by supplementation of the growth media with amino acids deemed to be a limiting factor in translation were not successful. The PDT protein remained in the insoluble fraction when the recombinant E. coli was grown at 37 degrees C but the protein became soluble when the bacteria were grown at 22 degrees C. The PDT protein was isolated via affinity chromatography on a NiCAM column. The protein was associated with five other proteins via disulfide bonds and non-covalent interactions. Following treatment with beta-mercaptoethanol, the PDT fusion was purified to homogeneity by preparative polyacrylamide gel electrophoresis with a yield of 45 microg/L of culture. Antisera generated against the purified PDT protein recognized the native toxins indicating that some, if not all, of the native epitopes were conserved.


Subject(s)
Diphtheria Toxin/biosynthesis , Escherichia coli/metabolism , Pertussis Toxin/biosynthesis , Recombinant Fusion Proteins/biosynthesis , Recombinant Fusion Proteins/isolation & purification , Tetanus Toxin/biosynthesis , Animals , Diphtheria Toxin/immunology , Electrophoresis, Polyacrylamide Gel , Female , Immune Sera , Mice , Pertussis Toxin/immunology , Recombinant Fusion Proteins/immunology , Tetanus Toxin/immunology
4.
J Immunol ; 177(4): 2584-91, 2006 Aug 15.
Article in English | MEDLINE | ID: mdl-16888020

ABSTRACT

Infection of mouse macrophages with Toxoplasma gondii elicits MAPK activation and IL-12 production, but host cell signaling pathways have not been clearly delineated. Here, we compared macrophage signaling in response to high virulence type I (RH) vs low virulence type II (ME49) strain infection. Tachyzoites of both strains induced p38 MAPK-dependent macrophage IL-12 release, although ME49 elicited 2- to 3-fold more cytokine than RH. IL-12 production was largely restricted to infected cells in each case. RH-induced IL-12 release did not require MyD88, whereas ME49-triggered IL-12 production was substantially dependent on this TLR/IL-1R adaptor molecule. MyD88 was also not required for RH-stimulated p38 MAPK activation, which occurred in the absence of detectable upstream p38 MAPK kinase activity. In contrast, ME49-driven p38 MAPK activation displayed an MyD88-dependent component. This parasite strain also induced MyD88-dependent activation of MKK4, an upstream activator of p38 MAPK. The results suggest that RH triggers MAPK activation and IL-12 production using MyD88-independent signaling, whereas ME49 uses these pathways as well as MyD88-dependent signaling cascades. Differences in host signaling pathways triggered by RH vs ME49 may contribute to the high and low virulence characteristics displayed by these parasite strains.


Subject(s)
Adaptor Proteins, Signal Transducing/physiology , Macrophages/parasitology , Signal Transduction/immunology , Toxoplasma/genetics , Animals , Cell Line , Cells, Cultured , Enzyme Activation/immunology , Female , Genotype , Immunity, Innate , Interleukin-12/biosynthesis , Macrophages/enzymology , Macrophages/immunology , Mice , Mice, Inbred C57BL , Mice, Knockout , Myeloid Differentiation Factor 88 , Species Specificity , Toxoplasma/isolation & purification , Toxoplasma/pathogenicity , Virulence , p38 Mitogen-Activated Protein Kinases/metabolism
5.
Infect Immun ; 74(3): 1916-23, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16495567

ABSTRACT

Toxoplasma gondii-infected macrophages are blocked in production of the proinflammatory cytokines interleukin-12 (IL-12) and tumor necrosis factor alpha (TNF-alpha) upon activation with lipopolysaccharide (LPS). Here, we used pathway-focused cDNA arrays to identify additional T. gondii-regulated transcriptional responses. Parasite infection decreased 57 (inclusive of IL-12 and TNF-alpha) and increased expression of 7 of 77 LPS-activated cytokine and cytokine-related genes. Interestingly, we found that the LPS-induced transcriptional response of the anti-inflammatory cytokine IL-10 was synergistically increased by T. gondii, results that we validated by conventional reverse transcription-PCR and enzyme-linked immunosorbent assay. Importantly, although the parasite exerted disparate effects in LPS-signaling leading to TNF-alpha versus IL-10 production, both responses required functional Toll-like receptor 4. We suggest that these effects represent parasite defense mechanisms to avoid or delay induction of antimicrobial activity and/or T-cell-mediated immunity during Toxoplasma infection.


Subject(s)
Interleukin-10/biosynthesis , Lipopolysaccharides/pharmacology , Macrophages/drug effects , Macrophages/parasitology , Oligonucleotide Array Sequence Analysis , Toxoplasma/physiology , Animals , Female , Gene Expression Regulation , Interleukin-10/immunology , Macrophages/immunology , Macrophages/metabolism , Mice , Toxoplasma/growth & development , Toxoplasma/pathogenicity
6.
Appl Environ Microbiol ; 70(8): 4569-74, 2004 Aug.
Article in English | MEDLINE | ID: mdl-15294787

ABSTRACT

A nontoxic mutant diphtheria toxin fragment A (DTA) was genetically fused in single, double, or triple copy to the major surface protein antigen P1 (SpaP) and surface expressed in Streptococcus gordonii DL-1. The expression was verified by Western immunoblotting. Mouse antisera raised against the recombinant S. gordonii recognized the native diphtheria toxinm suggesting the recombinant DTA was immunogenic. When given intranasally to mice with cholera toxin subunit B as the adjuvant, the recombinant S. gordonii expressing double copies of DTA (SpaP-DTA(2)) induced a mucosal immunoglobulin A response and a weak systemic immunoglobulin G response. S. gordonii SpaP-DTA(2) was able to orally colonize BALB/c mice for a 15-week period and elicited a mucosal response, but a serum immunoglobulin G response was not apparent. The antisera failed to neutralize diphtheria toxin cytotoxicity in a Vero cell assay.


Subject(s)
Diphtheria Toxin/immunology , Diphtheria Toxin/metabolism , Peptide Fragments/immunology , Peptide Fragments/metabolism , Recombinant Fusion Proteins/immunology , Recombinant Fusion Proteins/metabolism , Streptococcus/metabolism , Animals , Antibodies, Bacterial/blood , Antibodies, Bacterial/immunology , Bacterial Proteins/administration & dosage , Bacterial Proteins/genetics , Bacterial Proteins/immunology , Bacterial Proteins/metabolism , Diphtheria Toxin/administration & dosage , Diphtheria Toxin/genetics , Female , Immunization , Membrane Glycoproteins/administration & dosage , Membrane Glycoproteins/genetics , Membrane Glycoproteins/immunology , Membrane Glycoproteins/metabolism , Mice , Mice, Inbred BALB C , Neutralization Tests , Peptide Fragments/administration & dosage , Peptide Fragments/genetics , Recombinant Fusion Proteins/administration & dosage , Recombinant Fusion Proteins/genetics , Streptococcus/genetics , Streptococcus/growth & development , Streptococcus/immunology
7.
Vaccine ; 21(17-18): 1901-6, 2003 May 16.
Article in English | MEDLINE | ID: mdl-12706675

ABSTRACT

Secreted recombinant sialoglycoprotease fusion protein (Gcp-F) of Mannheimia (Pasteurella) haemolytica A1 was examined for its ability to protect cattle from experimental challenge with M. haemolytica A1. Five M. haemolytica vaccines were compared including Gcp-F, logarithmic phase culture supernate (Presponse) and Presponse enriched with Gcp-F, recombinant leukotoxin (rLkt) or both. All calves receiving Gcp-F had significant serum antibody responses to this antigen, measured by ELISA, prior to challenge. Those vaccinated with Gcp-F alone had significantly lower percent pneumonic tissue than unvaccinated controls and a trend (P=0.085, one-tailed test) to lower clinical scores. Calves receiving Presponse with Gcp-F and rLkt had lower percent pneumonic tissue than those receiving Presponse alone, and calves receiving Presponse enriched with Gcp-F and/or rLkt had lower mean clinical scores, but the differences were not significant. This trial demonstrates the protective capacity of sialoglycoprotease. While, remarkably, recombinant Gcp-F provided some protection alone the results support its practical potential as a component of a multiple antigen vaccine.


Subject(s)
Bacterial Vaccines/immunology , Cattle Diseases/immunology , Mannheimia haemolytica/immunology , Metalloendopeptidases/immunology , Pasteurella Infections/veterinary , Vaccines, Synthetic/immunology , Animals , Antibodies, Bacterial/blood , Bacterial Vaccines/chemical synthesis , Cattle , Mannheimia haemolytica/enzymology , Mannheimia haemolytica/pathogenicity , Pasteurella Infections/immunology , Recombinant Fusion Proteins/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...